FDA Approval and White Paper - Drug Discovery Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA Approval

White Paper

Predicting Drug Development in 2023

EG Life Sciences

FEBRUARY 15, 2023

The US Food and Drug Administration (FDA) approved around 26 novel drugs in 2022. Approval processes were slow in comparison to 2020 and 2021, where 53 and 50 approvals were achieved respectively. Going into the third year of the pandemic, we know that the virus still impacts industry operations.

Drug Development

Drug Development FDA Approval Drugs Virus

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Agency IQ

JULY 21, 2023

In parallel, FOCR developed a white paper that provided an overview of the potential regulatory applications for ctDNA in oncology. The paper, published in November 2021, primarily focused on the potential for ctDNA to serve as an early endpoint.

FDA

FDA Clinical Trials Treatment Trials

The Sweetest Thing

LifeSciVC

MARCH 12, 2025

Today there are 15 FDA-approved ADCs for oncology. Numerous white papers, scientific publications, presentations, and industry news articles focus on ADCs. The Right Formulation All FDA-approved ADCs are administered through intravenous injections, and all are approved for cancer indications.

FDA Approval

FDA Approval Disease FDA Science

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Predicting Drug Development in 2023

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

The Sweetest Thing

Webinars

Stay Connected